FINANCIAL NEWS

Dubai’s NewBridge secures $12m financing

22 Sep 2010

(MENAFN) Dubai-based NewBridge Pharmaceuticals said that it has completed its $12 million Series B financing, bringing the total amount raised to $16 million, Reuters reported.

The Series B financing round was led by Kuwait Life Sciences Company (KLSC), a subsidiary of National Technology Enterprises Company of Kuwait with participation by the previous investor Burrill Life Sciences Capital Fund III, L.P.

NewBridge is a specialty pharmaceutical, biologics, medical devices and diagnostics company serving the emerging markets of Africa, Middle East, Turkey, and Caspian regions.

More News